Epipen | USP | Pharmacopoeia | Reference Standards | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Epipen
USP

PharmaCompass Sponsored Ads

Contact Supplier

Sharp is a global leader in pharmaceutical packaging and clinical trial supply services.

Contact Supplier

xyz-pharma-m-2025-04-21

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

Contact Supplier

xyz-pharma-m-2025-04-14

Contact Supplier

Epipen

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 15 USDMF, 5 CEP/COS, 3 JDMF, 3 EU WC, 20 NDC API, 15 Listed Suppliers, $ API Reference Price

39 API Suppliers
15 USDMF
5 CEP/COS
3 JDMF
3 EU WC
20 NDC API
15 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

83 Drugs in Development

83 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

287 FDF Dossiers, 97 FDA Orange Book, 121 Europe, 19 Canada, 20 Australia, 15 South Africa, 15 Listed Dossiers

287 FDF Dossiers
97 FDA Orange Book
121 Europe
19 Canada
20 Australia
15 South Africa
15 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - 0.15MG/DELIVERY, INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - 0.3MG/DELIVERY, SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.15MG/DELIVERY, SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.1MG/DELIVERY, SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.3MG/DELIVERY, SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - EQ 1MG BASE/ML (EQ 1MG BASE/ML), SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - EQ 30MG BASE/30ML (EQ 1MG BASE/ML), SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - 10MG/10ML (1MG/ML), SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS - 1MG/ML (1MG/ML), SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - 30MG/30ML (1MG/ML), SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 0.15MG/0.3ML (0.15MG/0.3ML), SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 0.3MG/0.3ML (0.3MG/0.3ML), INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.15MG/DELIVERY, INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.3MG/DELIVERY, INJECTABLE;INJECTION - 0.005MG/ML;0.5%, INJECTABLE;INJECTION - 0.005MG/ML;1%, INJECTABLE;INJECTION - 0.005MG/ML;1.5%, INJECTABLE;INJECTION - 0.005MG/ML;2%, INJECTABLE;INJECTION - 0.01MG/ML;1%, INJECTABLE;INJECTION - 0.01MG/ML;2%, INJECTABLE;INJECTION - 0.02MG/ML;2%, INJECTABLE;INJECTION - 0.5%, INJECTABLE;INJECTION - 1%, INJECTABLE;INJECTION - 1.5%, INJECTABLE;INJECTION - 2%

INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - 0.15MG/DELIVERY
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - 0.3MG/DELIVERY
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.15MG/DELIVERY
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.1MG/DELIVERY
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.3MG/DELIVERY
SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - EQ 1MG BASE/ML (EQ 1MG BASE/ML)
SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - EQ 30MG BASE/30ML (EQ 1MG BASE/ML)
SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - 10MG/10ML (1MG/ML)
SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS - 1MG/ML (1MG/ML)
SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS - 30MG/30ML (1MG/ML)
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 0.15MG/0.3ML (0.15MG/0.3ML)
SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS - 0.3MG/0.3ML (0.3MG/0.3ML)
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.15MG/DELIVERY
INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS - EQ 0.3MG/DELIVERY
INJECTABLE;INJECTION - 0.005MG/ML;0.5%
INJECTABLE;INJECTION - 0.005MG/ML;1%
INJECTABLE;INJECTION - 0.005MG/ML;1.5%
INJECTABLE;INJECTION - 0.005MG/ML;2%
INJECTABLE;INJECTION - 0.01MG/ML;1%
INJECTABLE;INJECTION - 0.01MG/ML;2%
INJECTABLE;INJECTION - 0.02MG/ML;2%
INJECTABLE;INJECTION - 0.5%
INJECTABLE;INJECTION - 1%
INJECTABLE;INJECTION - 1.5%
INJECTABLE;INJECTION - 2%

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 9 Rochem International Inc, 19 SPI Pharma, 1 DKSH, 1 Pharm-RX Chemical, 4 Faran Shimi Pharmaceutical, 6 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Capital Farma, 11 Actylis, 2 Alcedo Pharmachem, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 9 BASF, 8 Beneo, 1 Bioplus Life Sciences, 2 DFE Pharma, 7 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 2 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 8 Kerry, 13 Microlex e.U, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 2 Prachin Chemical, 33 Roquette, 2 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 1 Ulanqab Kema New Material, 3 Vasa Pharmachem, 3 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

68 Fillers, Diluents & Binders, 39 Taste Masking, 32 Direct Compression, 22 Disintegrants & Superdisintegrants, 22 Chewable & Orodispersible Aids, 22 Thickeners and Stabilizers, 20 Coating Systems & Additives, 17 Film Formers & Plasticizers, 16 Granulation, 14 Parenteral, 14 Lubricants & Glidants, 13 Co-Processed Excipients, 10 Controlled & Modified Release, 8 Solubilizers, 4 Emulsifying Agents, 3 Topical, 2 API Stability Enhancers, 1 Soft Gelatin, 1 Rheology Modifiers

68 Fillers, Diluents & Binders
39 Taste Masking
32 Direct Compression
22 Disintegrants & Superdisintegrants
22 Chewable & Orodispersible Aids
22 Thickeners and Stabilizers
20 Coating Systems & Additives
17 Film Formers & Plasticizers
16 Granulation
14 Parenteral
14 Lubricants & Glidants
13 Co-Processed Excipients
10 Controlled & Modified Release
8 Solubilizers
4 Emulsifying Agents
3 Topical
2 API Stability Enhancers
1 Soft Gelatin
1 Rheology Modifiers

DIGITAL CONTENT

4 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 477 News #PharmaBuzz

4 Data Compilation #PharmaFlow
1 Stock Recap #PipelineProspector
477 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 105 Regulatory FDF Prices, 19 Annual Reports

4 US Medicaid Prescriptions
105 Regulatory FDF Prices
19 Annual Reports

MARKET PLACE

21 APIs, 26 FDF Dossiers

21 APIs
26 FDF Dossiers

PATENTS & EXCLUSIVITIES

77 US Patents

77 US Patents

REF. STANDARDS & IMPURITIES

3 USP, 3 Others

3 USP
3 Others

$ API Ref.Price (USD/KG) : 16,628 Xls

Filters

Reset all filters

Filters

FILTER :

filter Catalog Number Reset all filters

3 All

01 11A02740

02 11A03870

03 11A05850

filter Description Reset all filters

3 All

01 1D-Epinephrine

02 1Epinephrine Hydrochloride Methoxy Analog

03 1Epinine Hydroiodide

filter CAS Number Reset all filters

3 All

01 1150-05-0

02 1501-15-5

03 174571-90-7

Product Main Page

01

US Pharmacopeia

CPhI North America

USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

Contact Supplier

Contact Supplier

Digital Content

Epinine Hydroiodide

CAS Number : 501-15-5

Quantity Per Vial :

Price ($) : 500

Catalog Number : 1A05850

Current Lot :

Previous Lot :

NDC Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

US Pharmacopeia

CPhI North America

USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

Contact Supplier

Contact Supplier

Digital Content

Epinephrine Hydrochloride Methoxy Analog

CAS Number : 74571-90-7

Quantity Per Vial :

Price ($) : 1200

Catalog Number : 1A02740

Current Lot : 25 mg

Previous Lot :

NDC Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

US Pharmacopeia

CPhI North America

USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

Contact Supplier

Contact Supplier

Digital Content

D-Epinephrine

CAS Number : 150-05-0

Quantity Per Vial :

Price ($) : 525

Catalog Number : 1A03870

Current Lot : 25 mg

Previous Lot :

NDC Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!